Nutrien Closes Profertil Stake Sale, Advances Portfolio Strategy

Core Insights - Nutrien Ltd. has completed the sale of its 50% equity position in Profertil S.A. for approximately $600 million, marking a significant step in its strategic portfolio realignment efforts [1][2][8] - The proceeds from the sale will support Nutrien's capital-allocation priorities, including targeted growth investments, share repurchases, and debt reduction, aimed at increasing long-term free cash flow per share [2][8] - Since the fourth quarter of 2024, Nutrien has generated around $900 million in gross proceeds from asset divestitures, highlighting the scale of its portfolio rationalization activities [3][8] Financial Performance - Nutrien's shares have increased by 31.9% year to date, outperforming the industry average rise of 8.6% [5] - The strategic exit from Profertil aligns with Nutrien's focus on core markets and operations amid evolving industry dynamics, such as fertilizer demand and regional performance [3][8]